N-Terminal Pro–B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study

Journal of the American College of Cardiology

Volumn 71, Issue 11, 2018, Pages 1191-1200

  Januzzi, James L ^a,b,c   Chen Tournoux, Annabel A ^d   Christenson, Robert H ^e   Doros, Gheorghe ^c,f   Hollander, Judd E ^g   Levy, Phillip D ^h   Nagurney, John T ^a,b   Nowak, Richard M ⁱ   Pang, Peter S ^j   Patel, Darshita ^k   Peacock, W Franklin ^l   Rivers, E Joy ^k   Walters, Elizabeth L ^m   Gaggin, Hanna K ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY   (United States)

^g THOMAS JEFFERSON UNIVERSITY   (United States)

^h WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ HENRY FORD HEALTH SYSTEM   (United States)

^j INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k Roche Diagnostics Corporation   (United States)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

^m LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

acute heart failure; biomarker; diagnosis; NT proBNP; prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DYSPNEA; EMERGENCY WARD; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NORTH AMERICA; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

EID: 85042743372     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2018.01.021     Document Type: Article

References (27)

1. Januzzi, J.L. Jr., Rehman, S.U., Mohammed, A.A., et al. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol 58 (2011), 1881–1889.
2. Januzzi, J.L. Jr., Camargo, C.A., Anwaruddin, S., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005), 948–954.
3. Chen, A.A., Wood, M.J., Krauser, D.G., et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J 27 (2006), 839–845.
4. Maisel, A.S., Krishnaswamy, P., Nowak, R.M., et al., for the Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002), 161–167.
5. Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–e239.
6. Schmidt, M., Ulrichsen, S.P., Pedersen, L., Bøtker, H.E., Sørensen, H.T., Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study. Eur J Heart Fail 18 (2016), 490–499.
7. Christiansen, M.N., Køber, L., Weeke, P., et al. Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation 135 (2017), 1214–1223.
8. Baggish, A.L., van Kimmenade, R.R., Januzzi, J.L. Jr., The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 101 (2008), 43–48.
9. Januzzi, J.L., van Kimmenade, R., Lainchbury, J., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006), 330–337.
10. Baggish, A.L., van Kimmenade, R.R., Januzzi, J.L. Jr., Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure. Am J Cardiol 101 (2008), 49–55.
11. proBNP II Method Sheet/Package Insert. Roche.com. Roche Diagnostics USA, Indianapolis, IN. Available at: https://usdiagnostics.roche.com/en/documentation.html#/c/MS/n/KITPARAM1200MAT04842464160/pb. Accessed January 15, 2018.
12. Gaggin, H.K., Chen-Tournoux, A.A., Christenson, R.H., et al., for the ICON-RELOADED Investigators. Rationale and design of the ICON-RELOADED Study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department. Am Heart J 192 (2017), 26–37.
13. Mercaldo, N.D., Lau, K.F., Zhou, X.H., Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med 26 (2007), 2170–2183.
14. Jeffreys, H., Theory of Probability. 3rd Edition, 1961, Oxford University Press, Oxford, UK.
15. Krauser, D.G., Chen, A.A., Tung, R., Anwaruddin, S., Baggish, A.L., Januzzi, J.L. Jr., Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. J Card Fail 12 (2006), 452–457.
16. Anwaruddin, S., Lloyd-Jones, D.M., Baggish, A., et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47 (2006), 91–97.
17. Bayes-Genis, A., Lloyd-Jones, D.M., van Kimmenade, R.R., et al. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Arch Intern Med 167 (2007), 400–407.
18. Morello, A., Lloyd-Jones, D.M., Chae, C.U., et al. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 153 (2007), 90–97.
19. Ibrahim, I., Kuan, W.S., Frampton, C., et al. Superior performance of N-terminal pro brain natriuretic peptide for diagnosis of acute decompensated heart failure in an Asian compared with a Western setting. Eur J Heart Fail 19 (2017), 209–217.
20. Bradley, E.H., Curry, L., Horwitz, L.I., et al. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes 6 (2013), 444–450.
21. Peacock, W.F., Emerman, C., Costanzo, M.R., Diercks, D.B., Lopatin, M., Fonarow, G.C., Early vasoactive drugs improve heart failure outcomes. Congest Heart Fail 15 (2009), 256–264.
22. Green, S.M., Martinez-Rumayor, A., Gregory, S.A., et al. Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea. Arch Intern Med 168 (2008), 741–748.
23. Siebert, U., Januzzi, J.L. Jr., Beinfeld, M.T., Cameron, R., Gazelle, G.S., Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department. Am J Cardiol 98 (2006), 800–805.
24. Moe, G.W., Howlett, J., Januzzi, J.L., Zowall, H., for the Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study Investigators. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation 115 (2007), 3103–3110.
25. Maisel, A.S., Peacock, W.F., McMullin, N., et al. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol 52 (2008), 534–540.
26. McCullough, P.A., Nowak, R.M., McCord, J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106 (2002), 416–422.
27. Maisel, A., Mueller, C., Nowak, R., et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 55 (2010), 2062–2076.